Big Data and AI in the discovering

of a Covid-19 vaccine
Group 8
Yuqi CHU - Marie GROELLER - Xinyi LI - Akanksha THAKUR - Sizhao XIE
Too many Covid vaccines?

Usually With AI

● Months for potential mutation ● Providing Covid vaccine

analysis candidates within seconds
● Countless possible vaccine ● Accelerating clinical trials
candidates ● May even stay ahead of mutations
● Low developing speed
What is “AI”
AI is a computer science technology that allows machines to mimic humans and
perform tasks.

As a subset of AI, Machine Learning is the process of turning large data into usable
information through data training.

Using multiple layers of neural networks, Deep Learning is a subset of machine

learning that allows the machine to solve complex problems.
AI & Big Data

Big data and AI have a synergistic relationship.

Big data analytics leverages AI for better data analysis.
In turn, AI requires a massive scale of data to learn and improve decision-making
processes.
How does AI help?
Exploratory stage
● Machine learning approaches have been basic tools for identifying antigens from
protein sequences, which are the best possible targets for vaccines.

● AI-based approaches help the virtual vaccine discovery to predict protein

interactions and provide simulated protein sequences for further development
Clinical development
● Machine learning helps to clean up the patient data of a clinical trial for scientists
to analyze the result
● Improvement in quality and speed

● Smart Data Query

More than 30 days → About 22 hours
Manufacturing
● The challenges in manufacturing, storage, logistics, and issues related to the safety
and efficacy of different vaccine candidates can be overcome by AI algorithms.

● Risklick AI

AI-based analysis help foresee the different issues pharmaceutical companies

providing vaccines would face, notably during the production and distribution
phases of their product.
Quality control
● Data analysis can assess the effectiveness of existing vaccine on virus mutations

● By conducting data analytics on one of the world’s largest integrated health record
databases, the Clalit Research Institute and Harvard University researchers
examined the effectiveness of the Pfizer/BioNTech vaccine against the COVID-19
Delta variant among adolescents.

● The results indicated that fully vaccinated adolescents would see their risk of
symptomatic COVID-19 decrease by 93% compared to those unvaccinated.
Additionally, the risk of documented infection would decrease by 90%
New Possibilities
COVID-19 vaccine Health sector
related possibilities related possibilities

- Train AI to predict the most - Predict the outbreak of diseases through

likely mutations of the genome social media
- Forecast the spread of pandemics

Benefit: Benefit:
Faster and more accurate development of a More efficient containment policies
vaccine Fewer deaths
THANK YOU!
Any questions?